1-tert-butyl-3-(3-(5-(4-(piperidin-1-yl)piperidin-1-yl)-1H-benzo[d]imidazol-2-yl)-1H-indazol-4-yl)urea

ID: ALA379740

PubChem CID: 136038593

Max Phase: Preclinical

Molecular Formula: C29H38N8O

Molecular Weight: 514.68

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC(C)(C)NC(=O)Nc1cccc2[nH]nc(-c3nc4cc(N5CCC(N6CCCCC6)CC5)ccc4[nH]3)c12

Standard InChI:  InChI=1S/C29H38N8O/c1-29(2,3)33-28(38)32-22-8-7-9-23-25(22)26(35-34-23)27-30-21-11-10-20(18-24(21)31-27)37-16-12-19(13-17-37)36-14-5-4-6-15-36/h7-11,18-19H,4-6,12-17H2,1-3H3,(H,30,31)(H,34,35)(H2,32,33,38)

Standard InChI Key:  RQIXEOXMOHDTLC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 38 43  0  0  0  0  0  0  0  0999 V2000
   14.8849  -20.4103    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8779  -21.2376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5876  -21.6552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5971  -20.0026    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3121  -20.4163    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3069  -21.2429    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0915  -21.5032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.5816  -20.8375    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.0999  -20.1658    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3596  -19.3831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1455  -19.1378    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8792  -18.7177    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.3679  -18.0535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1504  -18.3172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7680  -17.7720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.6044  -16.9629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8176  -16.7019    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2033  -17.2489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6509  -15.8943    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.2741  -15.3462    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1101  -14.5418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.3284  -14.2782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7102  -14.8256    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8739  -15.6365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1646  -13.4700    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.7851  -12.9296    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6241  -12.1246    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8434  -11.8581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2233  -12.4031    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.3838  -13.2146    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5990  -19.1780    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.8857  -18.7642    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8876  -17.9396    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.1706  -19.1748    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.4575  -18.7610    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7403  -18.3477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8702  -18.0471    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0473  -19.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 17 18  1  0
 18 13  2  0
  8  9  2  0
 17 19  1  0
 19 20  1  0
  9  5  1  0
  4  1  2  0
  9 10  1  0
 10 11  1  0
  5  6  2  0
 19 24  1  0
 20 21  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 22 25  1  0
 25 26  1  0
 11 14  1  0
 13 12  1  0
 12 10  2  0
  2  3  2  0
  3  6  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 13 14  1  0
  4 31  1  0
  1  2  1  0
 31 32  1  0
 14 15  2  0
 32 33  2  0
  5  4  1  0
 32 34  1  0
 15 16  1  0
 34 35  1  0
  6  7  1  0
 35 36  1  0
 16 17  2  0
 35 37  1  0
  7  8  1  0
 35 38  1  0
M  END

Alternative Forms

  1. Parent:

    ALA379740

    ---

Associated Targets(Human)

HMEC (560 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FGFR1 Tclin Fibroblast growth factor receptor 1 (9149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FLT1 Tclin Vascular endothelial growth factor receptor 1 (6262 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Pdgfrb Platelet-derived growth factor receptor beta (494 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kdr Vascular endothelial growth factor receptor 2 (134 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.68Molecular Weight (Monoisotopic): 514.3169AlogP: 5.48#Rotatable Bonds: 4
Polar Surface Area: 104.97Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 10.88CX Basic pKa: 9.78CX LogP: 3.89CX LogD: 1.77
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.29Np Likeness Score: -1.47

References

1. McBride CM, Renhowe PA, Heise C, Jansen JM, Lapointe G, Ma S, Piñeda R, Vora J, Wiesmann M, Shafer CM..  (2006)  Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.,  16  (13): [PMID:16603352] [10.1016/j.bmcl.2006.03.069]

Source